Challenges in the diagnosis of post kala-azar dermal leishmaniasis

Indian Journal of Medical Research

Volumn 123, Issue 3, 2006, Pages 295-310

  Salotra, Poonam ^a   Singh, Ruchi ^a  

^a SAFDARJUNG HOSPITAL CAMPUS   (India)

Author keywords

Leishmania; Post kala azar dermal leishmaniasis (PKDL); Visceral leishmaniasis

Indexed keywords

ANTIMONY GLUCONATE; LEISHMANIA VACCINE; PARASITE ANTIBODY; PARASITE ANTIGEN;

AGGLUTINATION TEST; ANTIBODY DETECTION; CELLULAR IMMUNITY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOLOGICAL PROCEDURES; IMMUNOSUPPRESSIVE TREATMENT; LATEX AGGLUTINATION TEST; LEISHMANIA DONOVANI; MOLECULAR BIOLOGY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN DISEASE; SKIN LEISHMANIASIS; SKIN TEST; VISCERAL LEISHMANIASIS;

AGGLUTINATION TESTS; ANIMALS; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACIES; HUMANS; INDIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 33745203246     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. World Health Report. 2002. Geneva: World Health Organization; p. 186-91.
2. Bora D. Epidemiology of visceral leishmaniasis in India. Natl Med J India 1999; 2 : 62-8.
3. Ramesh V, Mukherjee A. Post-kala-azar dermal leishmaniasis. Int J Dermatol 1995; 34 : 85-91.
4. Zijlstra EE, El-Hassan AM. Leishmaniasis in Sudan: Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95 (Suppl 1) : S59-76.
5. Gasim S, El Hassan AM, Khalil EAG, Ismail A, Kadaru AM, Kharazmi A, et al. High levels of plasma interleukin 10 (IL10) and expression of IL10 by keratinocytes during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Clin Exp Immunol 1998; 111 : 64-9.
6. Gasim S, Theander TG, El Hassan AM. High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta Tropica 2000; 75 : 35-8.
7. Brahmachari UN. A new form of cutaneous leishmaniasis-dermal leishmanoid. Indian Med Gaz 1922; 57 : 125.
8. Zijlstra EE, Musa AM, Khalil EA, El Hassan IM, El-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 2003; 3 : 87-98.
9. Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 1992; 86 : 355-9.
10. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001; 95 : 239-43.
11. Addy M, Nandy A. Ten years of kala-azar in west Bengal, Part I. Did post - kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bull World Health Organ 1992; 70 : 341-6.
12. Dinesh DS, Kar SK, Kishore K, Palit A, Verma N, Gupta AK, et al. Screening sandflies for natural infection with Leishmania donovani using a non-radioactive probe based on the total DNA of the parasite. Ann Trop Med Parasitol 2000; 94 : 447-51.
13. Napier LE. Kala azar. The principles and practice of tropical medicine. New York: Macmillan; 1946 p. 135-77.
14. El Hassan AM, Ghalib HW, Zijlstra EE, Eltoum IA, Satti M, Ali MS, et al. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans R Soc Trop Med Hyg 1992; 86 : 245-8.
15. Khandpur S, Ramam M, Sharma VK, Salotra P, Singh MK, Malhotra A. Nerve involvement in Indian post kala-azar dermal leishmaniasis. Acta Derm Venereol 2004; 84 : 245-6.
16. Bittencourt A, Silva N, Straatmann A, Nunes VL, Follador I, Badaro R. Post-kala-azar dermal leishmaniasis associated with AIDS. Braz J Infect Dis 2002; 6 : 313-6.
17. Rios-Buceta L, Buezo GF, Penas PF, Tello ED, Montanes MA, Fernandez JF, et al. Post kala-azar dermal leishmaniasis in a HIV-patient. Int J Dermatol 1996; 35 : 303-4.
18. Ridolfo AL, Gervasoni C, Antinori S, Pizzuto M, Santambrogio S, Trabattoni D, et al. Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum. J Infect 2000; 40 : 199-202.
19. Nandy A, Addy M, Maji AK, Guha SK. Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis? Ann Trop Med Parasitol 2004; 98 : 651-4.
20. Nandy A, Addy M, Maji AK, Guha SK, Banerjee D, Chaudhuri D. Recurrence of kala-azar after PKDL: role of co-factors. Trop Med Int Health 1998; 3 : 76-8.
21. Singh RP. Observation on dermal leishmanoid in Bihar. Indian J Dermatol 1968; 13 : 59-63.
22. Ghosh MK, NandyA, Addy M, Maitra TK, Ghose AC. Subpopulations of T lymphocytes in peripheral blood, dermal lesions and lymph nodes of post kala-azar dermal leishmaniasis patients. Scand J Immunol 1995; 41 : 11-7.
23. El Harith A, Chowdhury S, Al-Masum A, Semiao-Santos S, Das PK, Akhter S, Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions. J Med Microbiol 1996; 44 : 141-6.
24. Haldar JP, Saha KC, Ghose AC. Serological profiles in Indian post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 1981; 75 : 514-7.
25. Osman OF, Oskam L, Kroon NC, Schoone GJ, Khalil ET, El-Hassan AM, et al. Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis. J Clin Microbiol 1998; 36 : 1621-4.
26. Salotra P, Sreenivas G, Beena KR, Mukherjee A, Ramesh V. Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods. J Clin Pathol 2003; 56: 840-3.
27. Sharma MC, Gupta AK, Verma N, Das VN, Saran R, Kar SK. Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases. J Commun Dis 2000; 32 : 67-8.
28. Mukherjee A, Ramesh V, Misra RS. Post-kala-azar dermal leishmaniasis: a light and electron microscopic study of 18 cases. J Cutan Pathol 1993; 20 : 320-5.
29. Singh N, Ramesh V, Arora VK, Bhatia A, Kubba A, Ramam M. Nodular post kala-azar dermal leishmaniasis: a distinct histopathological entity. J Cutan Pathol 1998; 25 : 95-9.
30. Beena KR, Ramesh V, Mukherjee A. Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala-azar dermal leishmaniasis. J Cutan Pathol 2003; 30 : 616-20.
31. Salotra P, Sreenivas G, Nasim AA, Subba Raju BV, Ramesh V. Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant K39 antigen. Clin Diagn Lab Immunol 2002; 9 : 370-3.
32. Singh S, Gilman-Sachs A, Chang KP, Reed SG. Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol 1995; 81 : 1000-3.
33. Saha S, Mazumdar T, Anam K, Ravindran R, Bairagi B, Saha B, et al. Leishmania promastigote membrane antigen-based enzyme linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. J Clin Microbiol 2005; 43: 1269-77.
34. Kaul P, Malla N, Kaur S, Mahajan RC, Ganguly NK. Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 2000; 94 : 173-5.
35. Salotra P, Raina A, Ramesh V. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 1999; 93 : 98-101.
36. Maalej IA, Chenik M, Louzir H, Ben Salah A, Bahloul C, Amri F, et al. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of mediterrean visceral lesihmaniasis. Am J Trop Med Hyg 2003; 68 : 312-20.
37. Badaro R, Benson D, Eulalio MC, Freire M, Cunha S, Netto EM, et al. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 1996; 173 : 758-61.
38. Ghedin E, Zhang WW, Charest H, Sundar S, Kenney RT, Matlashewski G. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol 1997; 4 : 530-5.
39. Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 2002; 9 : 951-8.
40. Houghton RL, Petrescu M, Benson DR, Skeiky YA, Scalone A, Badaro R, et al. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis 1998; 177 : 1339-44.
41. Jensen AT, Gasim S, Moller T, Ismail A, Gaafar A, Kemp M. Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP. Trans R Soc Trop Med Hyg 1999; 93 : 157-60.
42. Jensen AT, Ismail A, Gaafar A, El Hassan AM, Theander TG. Humoral and cellular immune responses to glucose regulated protein 78 - a novel Leishmania donovani antigen. Trop Med Int Health 2002; 7: 471-6.
43. Raj VS, Ghosh A, Dole VS, Madhubala R, Myler PJ, Stuart KD. Serodiagnosis of leishmaniasis with recombinant ORF F antigen. Am J Trop Med Hyg 1999; 61 : 482-7.
44. Chatterjee M, Jaffe CL, Sundar S, Basu D, Sen S, Mandal C. Diagnostic and prognostic potential of a competitive enzyme-linked immunosorbent assay for leishmaniasis in India. Clin Diagn Lab Immunol 1999; 6 : 550-4.
45. Bagchi AK, Tiwari S, Gupta S, Katiyar JC. The latex agglutination test: standardization and comparison with direct agglutination and dot-ELISA in the diagnosis of visceral leishmaniasis in India. Ann Trop Med Parasitol 1998; 92 : 159-63.
46. Singla N, Singh GS, Sundar S, Vinayak VK. Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India. Trans R Soc Trop Med Hyg 1993; 87 : 276-8.
47. Pal A, Mukherji K, Basu D, Naskar K, Mallick KK, Ghosh DK. Evaluation of direct agglutination test (DAT) and ELISA for serodiagnosis of visceral leishmaniasis in India. J Clin Lab Anal 1991; 5 : 303.
48. Schoone GJ, Hailu A, Kroon CC, Nieuwenhuys JL, Schallig HD, Oskam L. A fast agglutination screening test (FAST) for the detection of anti-Leishmania antibodies. Trans R Soc Trop Med Hyg 2001; 95 : 400-1.
49. Sundar S, Reed SG, Singh VP, Kumar PCK, Murray HW. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 1998; 351: 563-5.
50. Salotra P, Sreenivas G, Ramesh V, Sundar S. A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis. Br J Dermatol 2001; 145 : 630-2.
51. Singh S, Kumari V, Singh N. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin Diagn Lab Immunol 2002; 9 : 568-72.
52. Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, Groen J. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health 2001; 6 : 108-13.
53. Chappuis F, Rijal S, Singh R, Acharya P, Karki BM, Das ML, et al. Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal. Trop Med Int Health 2003; 8 : 277-85.
54. Jelinek T, Eichenlaub S, Loscher T. Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis. Eur J Clin Microbiol Infect Dis 1999; 18 : 669-70.
55. Carvalho SF, Lemos EM, Corey R, Dietze R. Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasis. Am J Trop Med Hyg 2003; 68 : 321-4.
56. Sarkari B, Chance M, Hommel M. Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen. Acta Trop 2002; 82 : 339-48.
57. Riera C, Fisa R, Lopez P, Ribera E, Carrio J, Falco V, et al. Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up. Eur J Clin Microbiol Infect Dis 2004; 23 : 899-904.
58. Sharma V, Chatterjee M, Mandal C, Sen S, Basu D. Rapid diagnosis of Indian visceral leishmaniasis using achatininH, a 9-O-acetylated sialic acid binding lectin. Am J Trop Med Hyg 1998; 58 : 551-4.
59. Neogy AB, Nandy A, Ghosh DB, Chowdhury AB. Modulation of the cell-mediated immune response in kala-azar and post kala-azar dermal leishmaniasis in relation to chemotherapy. Ann Trop Med Parasitol 1988; 82 : 27-34.
60. Garg R, Gupta SK, Tripathi P, Naik S, Sundar S, Dube A. Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani. Clin Exp Immunol 2005; 140 : 149-56.
61. Ismail A, El Hassan AM, Kemp K, Gasim S, Kadaru AE, Moller T, et al. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile. J Pathol 1999; 189 : 615-22.
62. Nandy A, Neogy AB, Chowdhury AB. Leishmanin test survey in an endemic village of Indian kala-azar near Calcutta. Ann Trop Med Parasitol 1987; 8 : 693-9.
63. Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol 2000; 143 : 136-43.
64. Zijlstra EE, Daifalla NS, Kager PA, Khalil EA, El-Hassan AM, Reed SG, et al. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 1998; 5: 717-20.
65. Tavares CAP, Fernandes AP, Melo MN. Molecular diagnosis of leishmaniasis. Expert Rev Mol Diagn 2003; 3 : 657-67.
66. Schallig HD, Oskam L. Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification. Trop Med Int Health 2002; 7: 641-51.
67. Lachaud L, Marchergui-Hammami S, Chabbert E, Dereure J, Dedet JP, Bastien P. Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis. J Clin Microbiol 2002; 40: 210-5.
68. Osman OF, Oskam L, Zijlstra EE, Kroon NC, Schoone GJ Khalil ET, et al. Evaluation of PCR for diagnosis of visceral leishmaniasis. J Clin Microbiol 1997; 35 : 2454-7.
69. Meredith SE, Zijlstra EE, Schoone GJ, Kroon CC, van Eys GJ, Schaeffer KU, et al. Development and application of the polymerase chain reaction for the detection and identification of Leishmania parasites in clinical material. Arch Inst Pasteur Tunis 1993; 70 : 419-31.
70. Hassan MQ, Ghosh A, Ghosh SS, Gupta M, Basu D, Mallik KK, et al. Enzymatic amplification of mini-exon-derived RNA gene spacers of Leishmania donovani: primers and probes for DNA diagnosis. Parasitology 1993; 107 : 509-17.
71. Salotra P, Sreenivas G, Pogue GP, Lee N, Nakhasi HL, Ramesh V, et al. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. J Clin Microbiol 2001; 39 : 849-54.
72. Andresen K, Gasim S, El Hassan AM, Khalil EA, Barker DC, Theander TG, et al. Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan. Trop Med Int Health 1997; 2 : 440-4.
73. Nuzum E, White F 3rd, Thakur CP, Dietze R, Wages J, Grogl M, et al. Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. J Infect Dis 1995; 171 : 751-4.
74. Martin-Sanchez J, Pineda JA, Andreu-Lopez M, Delgado J, Macias J, De La Rosa R, et al. The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum. Ann Trop Med Parasitol 2002; 96 : 669-77.
75. De Doncker S, Hutse V, Abdellati S, Rijal S, Singh Karki BM, Decuypere S, et al. A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects. Trans R Soc Trop Med Hyg 2005; 99: 25-31.
76. Pizzuto M, Piazza M, Senese D, Scalamogna C, Calattini S, Corsico L, et al. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol 2001; 39 : 357-61.
77. Campino L, Santos-Gomes GM, Pratlong F, Antunes F, Mauricio I, Dedet JP, et al. HIV/Leishmania co-infections in Portugal: diagnosis and isoenzyme characterization of Leishmania. Ann Trop Med Parasitol 1997; 91: 433-6.
78. Sreenivas G, Ansari NA, Kataria J, Salotra P. Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal leishmaniasis lesions. J Clin Microbiol 2004; 42 : 1777-8.
79. Yazdi AS, Puchta U, Flaig MJ, Sander CA. Laser-capture microdissection: applications in routine molecular dermatopathology. J Cutan Pathol 2004; 31 : 465-70.
80. Schulz A, Mellenthin K, Schonian G, Fleischer B, Drosten C. Detection, differentiation, and quantitation of pathogenic Leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol 2003; 41 : 1529-35.
81. Nicolas L, Prina E, Lang T, Milon G. Real-time PCR for detection and quantitation of Leishmania in mouse tissues. J Clin Microbiol 2002; 40 : 1666-9.
82. Bossolasco S, Gaiera G, Olchini D, Gulletta M, Martello L, Bestetti A, et al. Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis. J Clin Microbiol 2003; 41 : 5080-4.
83. Mary C, Faraut F, Lascombe L, Dumon H. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 2004; 42 : 5249-55.
84. Selvapandiyan A, Stabler K, Ansari NA, Kerby S, Riemenschneider J, Salotra P, et al. A novel semiquantitative fluorescence-based polymerase chain reaction assay for rapid simultaneous detection of bacterial and parasitic pathogens from blood. J Mol Diagn 2005; 7: 268-75.
85. Compton J. Nucleic acid sequence-based amplification. Nature 1991; 350 : 91-2.
86. Schneider P, Wolters L, Schoone G, Schallig H, Sillekens P, Hermsen R, et al. Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum. J Clin Microbiol 2005; 43 : 402-5.
87. Mauricio IL, Gaunt MW, Stothard JR, Miles MA. Genetic typing and phylogeny of the Leishmania donovani complex by restriction analysis of PCR amplified gp63 intergenic regions. Parasitology 2001; 122 : 393-403.
88. El Tai NO, Fari ME, Mauricio IL, Miles MA, Oskam L, El Safi SH, et al. Leishmania donovani: Intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing. Exp Parasitol 2001; 97 : 35-44.
89. Das Gupta S, Ghosh DK, Majumder HK. A cloned kinetoplast DNA mini-circle fragment from a Leishmania spp. specific for post-kala-azar dermal leishmaniasis strains. Parasitology 1991; 102 : 187-91.
90. Sreenivas G, Raju BV, Singh R, Selvapandiyan A, Duncan R, Sarkar D, et al. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal leishmaniasis in humans. J Clin Microbiol 2004; 42 : 1739-41.
91. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005; 309 : 436-42.